Jerry Li, PharmD

Clinical Pharmacology
Pfizer Inc

Jerry obtained his Bachelor's degree in Molecular Cell Biology at UC Berkeley and subsequently obtained his Pharm.D from University of Michigan College of Pharmacy. Jerry completed his training at Pfizer/UCSD in the clinical pharmacology oncology post-doctoral fellowship program, and is currently a Clinical Pharmacologist/Pharmacometrician at Pfizer supporting various programs in oncology.

Poster(s):

• 142: Population Pharmacokinetic-Pharmacodynamic (PKPD) Modeling Analyses of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Solid Tumors
  Monday, September 11, 2023

  5:00 PM - 7:00 PM PT

• 186: Population Pharmacokinetic Modeling of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Solid Tumors
  Monday, September 11, 2023

  5:00 PM - 7:00 PM PT